Monitoring of cellular resistance to cancer chemotherapy

Awtar Krishan, Poonam Arya

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cellular resistance to a broad spectrum of natural products used as antitumor drugs is believed to be a major cause for the failure of chemotherapy. Flow cytometry has been used for monitoring the expression of drug resistance markers, determining accumulation of fluorescent drugs, and for screening of drugs that enhance chemosensitivity by blocking efflux and enhancing drug retention. This article reviews recent developments in our understanding of the multiple drug resistance phenotype and the use of flow cytometry for the study of drug efflux and its modulation in human tumor cells.

Original languageEnglish
Pages (from-to)357-372
Number of pages16
JournalHematology/Oncology Clinics of North America
Volume16
Issue number2
DOIs
StatePublished - Jul 2 2002
Externally publishedYes

Fingerprint

Drug Therapy
Flow Cytometry
Pharmaceutical Preparations
Neoplasms
Preclinical Drug Evaluations
Multiple Drug Resistance
Biological Products
Drug Resistance
Antineoplastic Agents
Phenotype

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Monitoring of cellular resistance to cancer chemotherapy. / Krishan, Awtar; Arya, Poonam.

In: Hematology/Oncology Clinics of North America, Vol. 16, No. 2, 02.07.2002, p. 357-372.

Research output: Contribution to journalArticle

Krishan, Awtar ; Arya, Poonam. / Monitoring of cellular resistance to cancer chemotherapy. In: Hematology/Oncology Clinics of North America. 2002 ; Vol. 16, No. 2. pp. 357-372.
@article{2aaf0779cf4d4f618cd4f4c5e86aa793,
title = "Monitoring of cellular resistance to cancer chemotherapy",
abstract = "Cellular resistance to a broad spectrum of natural products used as antitumor drugs is believed to be a major cause for the failure of chemotherapy. Flow cytometry has been used for monitoring the expression of drug resistance markers, determining accumulation of fluorescent drugs, and for screening of drugs that enhance chemosensitivity by blocking efflux and enhancing drug retention. This article reviews recent developments in our understanding of the multiple drug resistance phenotype and the use of flow cytometry for the study of drug efflux and its modulation in human tumor cells.",
author = "Awtar Krishan and Poonam Arya",
year = "2002",
month = "7",
day = "2",
doi = "10.1016/S0889-8588(01)00016-8",
language = "English",
volume = "16",
pages = "357--372",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Monitoring of cellular resistance to cancer chemotherapy

AU - Krishan, Awtar

AU - Arya, Poonam

PY - 2002/7/2

Y1 - 2002/7/2

N2 - Cellular resistance to a broad spectrum of natural products used as antitumor drugs is believed to be a major cause for the failure of chemotherapy. Flow cytometry has been used for monitoring the expression of drug resistance markers, determining accumulation of fluorescent drugs, and for screening of drugs that enhance chemosensitivity by blocking efflux and enhancing drug retention. This article reviews recent developments in our understanding of the multiple drug resistance phenotype and the use of flow cytometry for the study of drug efflux and its modulation in human tumor cells.

AB - Cellular resistance to a broad spectrum of natural products used as antitumor drugs is believed to be a major cause for the failure of chemotherapy. Flow cytometry has been used for monitoring the expression of drug resistance markers, determining accumulation of fluorescent drugs, and for screening of drugs that enhance chemosensitivity by blocking efflux and enhancing drug retention. This article reviews recent developments in our understanding of the multiple drug resistance phenotype and the use of flow cytometry for the study of drug efflux and its modulation in human tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=0036080406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036080406&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(01)00016-8

DO - 10.1016/S0889-8588(01)00016-8

M3 - Article

C2 - 12094476

AN - SCOPUS:0036080406

VL - 16

SP - 357

EP - 372

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 2

ER -